Fig. 1From: The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndromeThe enucleation of erythroblasts in the MDS group was lower than that in the normal group. A Gating strategy for erythroblast enucleation. (A:a) All events are displayed on this plot of forward scatter area vs side scatter area, exclusion of dead cells and debris. (A:b-c) Exclusion of doublets on a plot of forward scatter area vs height and side scatter area vs height. (A:d) Singles are displayed. Hoechst negative cells are gated, these are mature red blood cells. B Flow cytometry detection of erythroblast enucleation in normal control individuals and patients with different subtypes of MDS. (B: a-d) Normal group of erythroblast enucleation. (B: e-j) Erythroblast enucleation in the MDS subtype was RA, RARS, RCMD, RAEB-1, RAEB-2 and MDS-U. C Quantitative analysis statistics of the rate of enucleation in the MDS and normal groups. D Pearson correlation analysis showed a positive correlation between enucleation and hemoglobin concentration in MDS patients (r = 0.5992, p < 0.01). The results are expressed as the mean ± SD, and * represents p < 0.05, ** represents p < 0.01, and *** represents p < 0.001Back to article page